M&AAstraZeneca buys Chinese Gracell Biotechnologies for $1.2bnLatest News Pharmaceutical giant AstrazZeneca wants to take over the Chinese company Gracell Biotechnologies in order to strengthen its cell therapy projects in a deal worth up to $1.2bn. Read more 28 December 2023 https://european-biotechnology.com/wp-content/uploads/2024/04/astrazeneca_discovery_center-original.jpg 540 960 Thomas Gabrielczyk /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Thomas Gabrielczyk2023-12-28 08:37:322024-07-09 12:25:07AstraZeneca buys Chinese Gracell Biotechnologies for $1.2bn